S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
The "Smart Money" Is Ready for May 1st Are You? (Ad)
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Your Money is Not Safe (Ad)
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Did You Get Your Free Bitcoin Yet? (Ad)
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
Closing prices for crude oil, gold and other commodities
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
The "Smart Money" Is Ready for May 1st Are You? (Ad)
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Your Money is Not Safe (Ad)
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Did You Get Your Free Bitcoin Yet? (Ad)
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
Closing prices for crude oil, gold and other commodities
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
The "Smart Money" Is Ready for May 1st Are You? (Ad)
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Your Money is Not Safe (Ad)
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Did You Get Your Free Bitcoin Yet? (Ad)
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
Closing prices for crude oil, gold and other commodities
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
The "Smart Money" Is Ready for May 1st Are You? (Ad)
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Your Money is Not Safe (Ad)
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Did You Get Your Free Bitcoin Yet? (Ad)
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
Closing prices for crude oil, gold and other commodities
Free Trial
NASDAQ:CYAD

Celyad Oncology (CYAD) Stock Price, News & Analysis

→ Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (From Paradigm Press) (Ad)
Free CYAD Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$0.40
▼
$0.65
50-Day Range
$0.59
▼
$0.85
52-Week Range
$0.46
▼
$3.07
Volume
3,009 shs
Average Volume
N/A
Market Capitalization
$15.91 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisHeadlinesSocial Media
CYAD stock logo

About Celyad Oncology Stock (NASDAQ:CYAD)

Celyad Oncology SA is a clinical-stage biotechnology company, which focuses on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer. It operates through the following segments: Cardiology and Immuno-Oncology. The Cardiology segment includes the company's Cardiopoiesis, Corquest, and C-Cathez platforms. The Immuno-Oncology segment consists of all assets developed based on the CAR-T cell platform. The company was founded by Michel Lussier, William Wijns, and Christian Homsy on July 24, 2007 and is headquartered in Mont-Saint-Guibert, Belgium.

CYAD Stock News Headlines

April 4, 2024 | finance.yahoo.com
Celyad Oncology Reports Full Year 2023 Financial Results and Recent Business Highlights
March 29, 2024 | seekingalpha.com
CSBR Champions Oncology, Inc.
April 20, 2024 | Crypto Swap Profits (Ad)
Did You Get Your Free Bitcoin Yet?
And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.
January 17, 2024 | finanznachrichten.de
Celyad Oncology SA: Celyad Oncology provides fourth quarter 2023 business update and 2024 outlook
January 16, 2024 | finance.yahoo.com
Celyad Oncology provides fourth quarter 2023 business update and 2024 outlook
December 17, 2023 | businesswire.com
Celyad Oncology: Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)
December 4, 2023 | finance.yahoo.com
Celyad Announces Management Change
November 14, 2023 | tmcnet.com
Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May
April 20, 2024 | Crypto Swap Profits (Ad)
Did You Get Your Free Bitcoin Yet?
And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.
November 11, 2023 | lse.co.uk
Celyad Oncology Share Price (CYAD.BR)
November 9, 2023 | finanznachrichten.de
Celyad Oncology SA: Celyad Oncology reports third quarter 2023 financial results and recent business highlights
November 9, 2023 | finance.yahoo.com
Celyad Oncology reports third quarter 2023 financial results and recent business highlights
September 26, 2023 | finanznachrichten.de
Celyad Oncology SA: Celyad Oncology announces the termination of its American Depository Receipt program
September 25, 2023 | marketwatch.com
Celyad Oncology to Terminate ADR Program
September 25, 2023 | finance.yahoo.com
Celyad Oncology announces the termination of its American Depository Receipt program
September 15, 2023 | finance.yahoo.com
Celyad Oncology SA: Publication of a Rectified Transparency Notification Received From Fortress Investment Group LLC
September 12, 2023 | businesswire.com
Celyad Oncology SA: Publication of a Transparency Notification Received from Tolefi SA
September 12, 2023 | ca.finance.yahoo.com
Celyad Oncology SA (CYAD.BR)
September 7, 2023 | finance.yahoo.com
Celyad Oncology SA: Publication of a Transparency Notification Received From Fortress Investment Group LLC
September 4, 2023 | finanznachrichten.de
Celyad Oncology SA: Celyad Oncology Reports First Half 2023 Financial Results and Recent Business Highlights
September 4, 2023 | finance.yahoo.com
Celyad Oncology Reports First Half 2023 Financial Results and Recent Business Highlights
September 4, 2023 | investing.com
Celyad Oncology (CYADY) Earnings Dates & Reports
August 29, 2023 | finance.yahoo.com
Celyad Oncology Receives Approximately EUR 9.8m in Private Placement Commitments From Historical Shareholders
August 25, 2023 | finanznachrichten.de
Celyad Oncology SA: Celyad Oncology receives approximately EUR 9.8m in private placement commitments from historical shareholders
July 19, 2023 | investing.com
Celyad Oncology SA (CYADY)
May 16, 2023 | finanznachrichten.de
Celyad Oncology SA: Celyad Oncology announces receipt of Nasdaq delisting notice
May 15, 2023 | finance.yahoo.com
Celyad Oncology Announces Receipt of Nasdaq Delisting Notice
See More Headlines
Receive CYAD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Celyad Oncology and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/19/2024
Fiscal Year End
12/31/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:CYAD
CUSIP
N/A
CIK
1637890
Web
www.celyad.com
Phone
(210) 039-4100
Fax
321-039-4141
Employees
95
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$110,000.00
Price / Sales
144.65
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.20 per share
Price / Book
3.00

Miscellaneous

Outstanding Shares
26,520,000
Free Float
26,276,000
Market Cap
$15.91 million
Optionable
Not Optionable
Beta
N/A
Metaverse Stocks And Why You Can't Ignore Them Cover
Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

  • Georges Rawadi
    Chief Executive Officer & Executive Director
  • David Georges
    Vice President-Finance & Administration
  • Eytan Breman
    Director-Research & Development
  • An Phan
    Head-Legal

Key Competitors

View All Competitors

CYAD Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Celyad Oncology own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Celyad Oncology investors own include Galapagos (GLPG), Cellectis (CLLS), Gilead Sciences (GILD), Intercept Pharmaceuticals (ICPT), ChromaDex (CDXC), bluebird bio (BLUE), SCYNEXIS (SCYX), Neurocrine Biosciences (NBIX), AbbVie (ABBV) and argenx (ARGX).

When did Celyad Oncology IPO?

Celyad Oncology (CYAD) raised $99 million in an initial public offering (IPO) on Friday, June 19th 2015. The company issued 1,400,000 shares at a price of $70.98 per share. UBS Investment Bank and Piper Jaffray served as the underwriters for the IPO and Petercam Bryan, Garnier, LifeSci Capital and Lake Street Capital Markets were co-managers.

This page (NASDAQ:CYAD) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners
The “Perfect Storm” for Gold
Gold Safe Exchange
Biden’s $374B Giveaway Into This Sector
DTI
SHOCKING Crypto Leak…
Crypto 101 Media
Your Money is Not Safe
American Alternative
The #1 Crypto for 2024
InvestorPlace
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
Urgent alert: open this for a huge profit potential
Timothy Sykes
Tiny Biotech Stock Wins $75 Billion Patent
Behind the Markets